ciprofloxacin has been researched along with Dysmyelopoietic Syndromes in 10 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In a single-center open-label prospective study, a total of 134 marrow transplant recipients with hematologic malignancies were randomly assigned to a bacterial decontamination medication using metronidazole and ciprofloxacin (n = 68) or ciprofloxacin alone (n = 66) during 5 weeks posttransplant." | 9.09 | Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and ( Beelen, DW; Elmaagacli, A; Hirche, H; Müller, KD; Schaefer, UW, 1999) |
| "In a single-center open-label prospective study, a total of 134 marrow transplant recipients with hematologic malignancies were randomly assigned to a bacterial decontamination medication using metronidazole and ciprofloxacin (n = 68) or ciprofloxacin alone (n = 66) during 5 weeks posttransplant." | 5.09 | Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and ( Beelen, DW; Elmaagacli, A; Hirche, H; Müller, KD; Schaefer, UW, 1999) |
| "Tumor necrosis factor-alpha (TNF-alpha) levels were measured in the serum (sTNF-alpha) or bone marrow (BM) biopsies of 43 patients with myelodysplastic syndromes (MDS) who subsequently received therapy with a combination of pentoxifylline and ciprofloxacin (PC) with or without dexamethasone (PCD)." | 5.08 | Tumor necrosis factor-alpha levels decrease with anticytokine therapy in patients with myelodysplastic syndromes. ( Dar, S; Qawi, H; Raza, A; Reza, S; Shetty, V, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zlitni, S | 1 |
| Bishara, A | 1 |
| Moss, EL | 1 |
| Tkachenko, E | 1 |
| Kang, JB | 1 |
| Culver, RN | 1 |
| Andermann, TM | 1 |
| Weng, Z | 1 |
| Wood, C | 1 |
| Handy, C | 1 |
| Ji, HP | 1 |
| Batzoglou, S | 1 |
| Bhatt, AS | 1 |
| Gagneux-Brunon, A | 1 |
| Pillet, S | 1 |
| Laurent, B | 1 |
| Mariat, C | 1 |
| Michalet, M | 1 |
| Lucht, F | 1 |
| Botelho-Nevers, E | 1 |
| Erikci, AA | 1 |
| Ozturk, A | 1 |
| Karagoz, B | 1 |
| Bilgi, O | 1 |
| Turken, O | 1 |
| Top, C | 1 |
| Kandemir, EG | 1 |
| Smith, RE | 1 |
| Bryant, J | 1 |
| DeCillis, A | 1 |
| Anderson, S | 1 |
| Kim, MK | 1 |
| Lee, JL | 1 |
| Cho, HS | 1 |
| Bae, SH | 1 |
| Ryoo, HM | 1 |
| Lee, KH | 1 |
| Hyun, MS | 1 |
| Nemunaitis, J | 1 |
| Rosenfeld, C | 1 |
| Getty, L | 1 |
| Boegel, F | 1 |
| Meyer, W | 1 |
| Jennings, LW | 1 |
| Zeigler, Z | 1 |
| Shadduck, R | 1 |
| Reza, S | 1 |
| Shetty, V | 1 |
| Dar, S | 2 |
| Qawi, H | 2 |
| Raza, A | 2 |
| Beelen, DW | 1 |
| Elmaagacli, A | 1 |
| Müller, KD | 1 |
| Hirche, H | 1 |
| Schaefer, UW | 1 |
| Lisak, L | 1 |
| Andric, T | 1 |
| Andrews, C | 1 |
| Venugopal, P | 1 |
| Gezer, S | 1 |
| Gregory, S | 1 |
| Loew, J | 1 |
| Robin, E | 1 |
| Rifkin, S | 1 |
| Hsu, WT | 1 |
| Huang, RW | 1 |
| Novitzky, N | 1 |
| Mohamed, R | 1 |
| Finlayson, J | 1 |
| du Toit, C | 1 |
4 trials available for ciprofloxacin and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
The hematologic response to anti-apoptotic cytokine therapy: results of pentoxifylline, ciprofloxacin, and dexamethasone treatment for patients with myelodysplastic syndrome.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Apoptosis; Ciprofloxacin; | 2006 |
Pentoxifylline and ciprofloxacin in patients with myelodysplastic syndrome. A phase II trial.
Topics: Adult; Aged; Ciprofloxacin; Colony-Forming Units Assay; Drug Therapy, Combination; Female; Hematopoi | 1995 |
Tumor necrosis factor-alpha levels decrease with anticytokine therapy in patients with myelodysplastic syndromes.
Topics: Aged; Aged, 80 and over; Biopsy; Ciprofloxacin; Dexamethasone; Drug Therapy, Combination; Female; He | 1998 |
Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bone Marrow Transplantation; Ciprofloxacin; Drug Therapy, | 1999 |
6 other studies available for ciprofloxacin and Dysmyelopoietic Syndromes
| Article | Year |
|---|---|
Strain-resolved microbiome sequencing reveals mobile elements that drive bacterial competition on a clinical timescale.
Topics: Anti-Infective Agents; Azacitidine; Azithromycin; Bacteria; Ciprofloxacin; Diet; DNA, Bacterial; Fec | 2020 |
A case of BK virus nephropathy in a stem cell transplant recipient: a rare or under-recognized cause for Acute Kidney injury.
Topics: Acute Kidney Injury; Anti-Bacterial Agents; BK Virus; Ciprofloxacin; Cord Blood Stem Cell Transplant | 2015 |
Results of combination therapy with amifostine, pentoxifylline, ciprofloxacin and dexamethasone in patients with myelodysplastic syndrome and acute myeloid leukemia.
Topics: Adult; Aged; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Ciprofloxacin; Dexamethason | 2008 |
Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: the National Surgical Adjuvant Breast and Bowel Project Experience.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cipr | 2003 |
Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone.
Topics: Adult; Aged; Aged, 80 and over; Amifostine; Anorexia; Antineoplastic Combined Chemotherapy Protocols | 2000 |
Increased apoptosis of bone marrow cells and preserved proliferative capacity of selected progenitors predict for clinical response to anti-inflammatory therapy in myelodysplastic syndromes.
Topics: Anti-Inflammatory Agents; Antigens, CD34; Apoptosis; Blood Transfusion; Bone Marrow Cells; Cell Divi | 2000 |